Clinical CareEPA Ban on Sewering Hazardous Waste Drugs Takes Effect Wednesday
The sewering ban, one of the more stringent changes outlined in EPA's rule, is the only part of the rule...
StrategyDrugmakers Master Rolling Out Their Own Generics To Stifle Competition
Critics say authorized generics hurt long-term competition and often perversely increase costs, even in the short term.
StrategyAzar Outlines Drug Importation Plan After Reversing His Position
The breadth of the plan's impact will depend in large part on proposals brought forward by the industry.
Clinical CareCommon Medications Can Masquerade As Dementia In Seniors
Older adults are highly susceptible to negative responses anticholinergic drugs?a wide-ranging class of medications.
Trump Has Blessed States' Exploration Of Importing Drugs. Will It Catch On?
The states' plans signal how frustration among consumers is putting pressure on federal and state officials.
FinanceTrump Issues Executive Order on Healthcare Price Transparency
Officials say the move will result in lower healthcare costs by unleashing competition. Some industry stakeholders are disputing that claim.
Clinical Care'Unprecedented' Survival Benefit Vanishes in Confirmatory Cancer Trial
Over $1 billion in sales for drug possibly without benefit.
StrategyTransparency Bills May Have Unintended Consequences
Lawmakers hear concerns about provisions on drug samples, price increases.
StrategyGottlieb's Last Day: FDA Commissioner Returns to Conservative Think Tank
The part-time role will reportedly occupy only about six hours of Gottlieb's time each month, leaving quite a bit of...
InnovationFDA Moves to Curb Insulin Price Hikes as Pressure on Manufacturers Mounts
Insulin manufacturers have long been criticized for raising their list prices year after year. Now the FDA aims to make...
StrategyGottlieb Confident in FDA's Direction as His Departure Nears
The decision to leave the agency did not come easily, but the commissioner said he feels good about where things...